PROVING THE EFFICACY OF MANGIFERIN AS A NEUROPROTECTIVE DRUG USING DOCKING STUDIES. biotech [Internet]. 2018 Jul. 30 [cited 2025 Dec. 10];3(1):10-6. Available from: https://proceedings.tiikmpublishing.com/index.php/biotech/article/view/152